statistiche ricercatore

Continente	#
NA - Nord America	1.434
AS - Asia	419
EU - Europa	377
SA - Sud America	120
AF - Africa	11
OC - Oceania	4
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2.366

Nazione	#
US - Stati Uniti d'America	1.412
SG - Singapore	144
CN - Cina	119
BR - Brasile	87
UA - Ucraina	76
IT - Italia	57
VN - Vietnam	57
RU - Federazione Russa	56
SE - Svezia	54
FR - Francia	33
DE - Germania	24
TR - Turchia	20
GB - Regno Unito	18
IE - Irlanda	17
AR - Argentina	15
BD - Bangladesh	15
FI - Finlandia	15
CA - Canada	10
HK - Hong Kong	10
IN - India	10
JP - Giappone	8
EC - Ecuador	7
MX - Messico	7
PL - Polonia	7
ID - Indonesia	5
KR - Corea	5
PK - Pakistan	5
ES - Italia	4
IQ - Iraq	4
NL - Olanda	4
ZA - Sudafrica	4
AU - Australia	3
CO - Colombia	3
MA - Marocco	3
AE - Emirati Arabi Uniti	2
AM - Armenia	2
AT - Austria	2
CL - Cile	2
CZ - Repubblica Ceca	2
HU - Ungheria	2
IL - Israele	2
JM - Giamaica	2
NP - Nepal	2
PH - Filippine	2
PT - Portogallo	2
PY - Paraguay	2
UY - Uruguay	2
AZ - Azerbaigian	1
BE - Belgio	1
CH - Svizzera	1
DZ - Algeria	1
EU - Europa	1
GT - Guatemala	1
HN - Honduras	1
IR - Iran	1
JO - Giordania	1
KE - Kenya	1
KG - Kirghizistan	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
LU - Lussemburgo	1
NA - Namibia	1
NZ - Nuova Zelanda	1
PE - Perù	1
PS - Palestinian Territory	1
RO - Romania	1
TN - Tunisia	1
TT - Trinidad e Tobago	1
VE - Venezuela	1
Totale	2.366

Nome	#
Urinary Cell-Free DNA: Potential and Applications	245
Studying Copy Number Variations in Cell-Free DNA: The Example of AR in Prostate Cancer	227
Association among metabolic syndrome, inflammation, and survival in prostate cancer	207
Androgen receptor in breast cancer: A wolf in sheep's clothing? A lesson from prostate cancer	206
Urinary Cell-Free DNA: Isolation, Quantification, and Quality Assessment	206
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer	202
Carcinosarcoma of the prostate: case report with molecular and histological characterization	180
Clinical implications of extracellular vesicles in prostate and breast cancer	177
Plasma androgen receptor and serum chromogranin A in advanced prostate cancer	176
Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancer	171
Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?	162
Detection and Investigation of Extracellular Vesicles in Serum and Urine Supernatant of Prostate Cancer Patients	117
Know your enemy: Genetics, aging, exposomic and inflammation in the war against triple negative breast cancer.	103
Totale	2.379

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	22	0	0	0	0	0	0	0	0	0	0	0	22
2021/2022	149	32	5	1	27	5	7	4	7	11	10	3	37
2022/2023	128	18	3	15	1	16	27	0	4	19	7	9	9
2023/2024	49	12	6	1	9	3	6	2	6	0	0	0	4
2024/2025	272	11	6	39	14	1	11	62	3	56	28	21	20
2025/2026	606	33	45	96	191	74	26	50	8	31	15	36	1
Totale													2.379